Tempol prevents altered K+ channel regulation of afferent arteriolar tone in diabetic rat kidney

Hypertension

Volumn 59, Issue 3, 2012, Pages 657-664

  Troncoso Brindeiro, Carmen M ^a   Lane, Pascale H ^a   Carmines, Pamela K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

ATP sensitive K channels; diabetes mellitus; inward rectifier K channels; ROMK; Tempol

Indexed keywords

BARIUM ION; DRINKING WATER; GLIBENCLAMIDE; HYDROETHIDINE; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL KIR1.1; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.1; INWARDLY RECTIFYING POTASSIUM CHANNEL SUR2B; MESSENGER RNA; POTASSIUM CHANNEL BLOCKING AGENT; TEMPOL; TERTIAPIN Q; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTERY TONE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; MALE; MICROVASCULARIZATION; NEPHRON; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL AFFERENT ARTERIOLE; RENAL ARTERY; SMOOTH MUSCLE FIBER; VASODILATATION;

ANIMALS; ANTIOXIDANTS; ARTERIOLES; BLOTTING, WESTERN; CYCLIC N-OXIDES; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION; KIDNEY CORTEX; MALE; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SPIN LABELS;

EID: 84857634168     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.184218     Document Type: Article

References (33)

1. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC, Sowers JR. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134-1146. (Pubitemid 29416243)
2. Ha H, Kim KH. Role of oxidative stress in the development of diabetic nephropathy. Kidney Int. 1995;48(suppl 51):S18-S21.
3. Asaba K, Tojo A, Onozato ML, Goto A, Fujita T. Double-edged action of SOD mimetic in diabetic nephropathy. J Cardiovasc Pharmacol. 2007; 49:13-19. (Pubitemid 46184326)
4. Peixoto EB, Pessoa BS, Biswas SK, Lopes de Faria JB. Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension. Am J Nephrol. 2009;29:309-318.
5. Ishii N, Patel KP, Lane PH, Taylor T, Bian K, Murad F, Pollock JS, Carmines PK. Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol. 2001;12: 1630-1639. (Pubitemid 32674425)
6. Schnackenberg CG, Wilcox CS. The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int. 2001; 59:1859-1864. (Pubitemid 32336801)
7. + channels on afferent arteriolar diameter in diabetes mellitus. J Am Soc Nephrol. 2000;11:1199-1207. (Pubitemid 30416215)
8. Troncoso Brindeiro CM, Fallet RW, Lane PH, Carmines PK. Potassium channel contributions to afferent arteriolar tone in normal and diabetic rat kidney. Am J Physiol Renal Physiol. 2008;295:F171-F178.
9. Liu YP, Gutterman DD. Oxidative stress and potassium channel function. Clin Exp Pharmacol Physiol. 2002;29:305-311. (Pubitemid 34227065)
10. Carmines PK, Navar LG. Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II. Am J Physiol Renal Fluid Electrolyte Physiol. 1989;256:F1015-F1020.
11. Casellas D, Navar LG. In vitro perfusion of juxtamedullary nephrons in rats. Am J Physiol Renal Fluid Electrolyte Physiol. 1984;246:F349-F358. (Pubitemid 14146768)
12. + channel inhibition by tertiapin-Q. Biochemistry. 1999;38:14294-14301.
13. Zalba G, Fortuno A, Orbe J, San JG, Moreno MU, Belzunce M, Rodriguez JA, Beloqui O, Paramo JA, Diez J. Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase- 9: implications for human atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:587-593.
14. 2+]i responses to ANG II. Am J Physiol Renal Physiol. 2005;288:F658-F664. (Pubitemid 40381732)
15. Sasser JM, Sullivan JC, Hobbs JL, Yamamoto T, Pollock DM, Carmines PK, Pollock JS. Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. J Am Soc Nephrol. 2007;18: 143-154. (Pubitemid 46053429)
16. Ohishi K, Okwueze MI, Vari RC, Carmines PK. Juxtamedullary microvascular dysfunction during the hyperfiltration stage of diabetes mellitus. Am J Physiol Renal Fluid Electrolyte Physiol. 1994;267:F99-F105.
17. Kubo Y, Adelman JP, Clapham DE, Jan LY, Karschin A, Kurachi Y, Lazdunski M, Nichols CG, Seino S, Vandenberg CA. International Union of Pharmacology: LIV-nomenclature and molecular relationships of inwardly rectifying potassium channels. Pharmacol Rev. 2005;57: 509-526. (Pubitemid 43036438)
18. Wilcox CS, Pearlman A. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev. 2008;60:418-469.
19. Wilcox CS. Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol Ther. 2010;126:119-145.
20. McCord JL, Tsuchimochi H, Yamauchi K, Leal AK, Kaufman MP. Tempol attenuates the exercise pressor reflex independently of neutralizing reactive oxygen species in femoral arterial ligated rats. J Appl Physiol. 2011;111:971-979.
21. Xu H, Bian X, Watts SW, Hlavacova A. Activation of vascular BK channel by tempol in DOCA-salt hypertensive rats. Hypertension. 2005; 46:1154-1162. (Pubitemid 41533019)
22. Zhang Y, Jang R, Mori TA, Croft KD, Schyvens CG, McKenzie KU, Whitworth JA. The anti-oxidant Tempol reverses and partially prevents adrenocorticotrophic hormone-induced hypertension in the rat. J Hypertens. 2003;21:1513-1518. (Pubitemid 36994130)
23. Jay D, Hitomi H, Griendling KK. Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med. 2006;40:183-192. (Pubitemid 43069343)
24. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004; 24:816-823. (Pubitemid 38620857)
25. Wei EP, Kontos HA, Beckman JS. Mechanisms of cerebral vasodilation by superoxide, hydrogen peroxide, and peroxynitrite. Am J Physiol Heart Circ Physiol. 1996;271:H1262-H1266.
26. + channels. Am J Physiol Heart Circ Physiol. 2005;289:H2244-H2250. (Pubitemid 41507379)
27. Hanna ST, Cao K, Sun X, Wang R. Mediation of the effect of nicotine on Kir6.1 channels by superoxide anion production. J Cardiovasc Pharmacol. 2005;45:447-455. (Pubitemid 40627964)
28. +-mediated vasodilation. Circ Res. 2000;87:160-166. (Pubitemid 30616913)
29. Wang WH. Regulation of ROMK (Kir1.1) channels: new mechanisms and aspects. Am J Physiol Renal Physiol. 2006;290:F14-F19.
30. BelAiba RS, Djordjevic T, Bonello S, Artunc F, Lang F, Hess J, Gorlach A. The serum- and glucocorticoid-inducible kinase Sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by thrombin. Circ Res. 2006;98:828-836.
31. Ohishi K, Carmines PK. Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J Am Soc Nephrol. 1995;5:1559-1566.
32. Giunti S, Barit D, Cooper ME. Diabetic nephropathy: from mechanisms to rational therapies. Minerva Med. 2006;97:241-262. (Pubitemid 44483595)
33. Pearson JG. Pharmacokinetics of glyburide. Am J Med. 1985;79:67-71. (Pubitemid 16169755)